semaglutide tablet or injection What to Know About Semaglutide: Oral Tablets vs. Injections Semaglutide: Injection Home Kit –

PubMed abstract Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes Authors: Palmer AJ

Key Takeaways on Wegovy Insurance Coverage FDA-approved for weight management : Wegovy (semaglutide 2.4mg) is approved for chronic weight management in adults with BMI 30, or BMI 27 with at least one weight-related comorbidity Commercial insurance coverage is expanding : About 40-50% of employer-sponsored plans now cover GLP-1 medications for weight loss, up from under 20% in 2023 Medicare does NOT cover Wegovy for weight loss : Federal law prohibits Medicare Part D from covering drugs prescribed solely for weight management no exceptions List price without insurance : Approximately $1,349/month ($16,188/year) at retail pharmacy Savings programs available : Novo Nordisk offers a savings card reducing cost to as low as $0-$25/month for eligible commercially insured patients Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk

Image courtesy of Parade At the time, being in my late 20s, I felt as if I should have been aging into my 50s to 60s

In 1972, Svetlana Mojsov was a PhD student at Rockefeller University in New York City under the tutelage of biochemist Bruce Merrifield, who had developed a new, efficient way to produce peptides in a lab (for which he would win a Nobel Prize in 1984) called solid-phase peptide synthesis. For her doctoral thesis, Mojsov used this method to achieve something that had eluded researchers for decades: She successfully synthesized glucagon, a complex hormone the body produces to raise blood sugar levels when necessary, which was of particular interest to endocrinologists as a potential treatment for diabetes